🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Primary trial objective in this single arm trial is to assess the safety an...
Status
Completed
Location
Department of Thoracic Oncology, Netherlands Cancer Instiute - Antoni van Leeuwenhoek Hospital
Start Date
2009-04
Trial ID
NCT00879866
Treatments Being Tested
To evaluate safety, tolerance and efficacy of TASO(TGF-β2 targeting anti-se...
Status
Completed
Location
Seoul National University Hospital
Start Date
2021-03-09
Trial ID
NCT04862767
Treatments Being Tested
In this i-SABR (immunotherapy + Stereotactic Ablative Body Radiation) trial...
Status
Completed
Location
University of Texas Southwestern Medical Center
Start Date
2013-10-02
Trial ID
NCT01896271
Treatments Being Tested
This study is a randomized, double-blind, placebo-controlled, multi-center,...
Status
Withdrawn
Location
Multiple Locations
Start Date
2021-10
Trial ID
NCT03532958
Treatments Being Tested
RATIONALE: Vaccines made from white blood cells treated with antigens may m...
Status
Completed
Location
Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support
Start Date
1997-04
Trial ID
NCT00019214
Treatments Being Tested
Monoclonal antibodies can locate tumor cells and either kill them or delive...
Status
Completed
Location
Children's Oncology Group
Start Date
2001-01
Trial ID
NCT00005576
Treatments Being Tested
Evaluation of The Efficacy And Safety of Tislelizumab (PD-1) Monoclonal Ant...
Status
Unknown
Location
Multiple Locations
Start Date
2024-05-01
Trial ID
NCT06394791
Treatments Being Tested
This will be a phase II trial testing if the combination of SBRT and L19-IL...
Status
Withdrawn
Location
MAASTRO clinic
Start Date
2015-12
Trial ID
NCT02735850
Treatments Being Tested
The goal of the Phase I part of this clinical research study is to find the...
Status
Terminated
Location
University of Texas MD Anderson Cancer Center
Start Date
2013-02
Trial ID
NCT01409174
Treatments Being Tested
Human recombinant interleukin-2 (rhIL-2) is a biological signalling protein...
Status
Completed
Location
Service d'Endocrinologie Pédiatrique
Start Date
2013-06-27
Trial ID
NCT01862120
Treatments Being Tested